#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Median nerve pathology in acromegaly


Authors: I. Ságová 1,2;  P. Vaňuga 1;  D. Pávai 1;  D. Kantárová 2;  D. Holováčová 3;  E. Huľo 4;  M. Mokáň 2;  J. Payer 5;  P. Letavay 6
Authors‘ workplace: Endokrinologické oddelenie, Národný endokrinologický a diabetologický ústav Ľubochňa, Slovensko 1;  1. interná klinika UN a JLFUK, Martin, Slovensko 2;  I. Interná klinika LF UK a UNB, Bratislava, Slovensko 3;  Oddelenie všeobecnej a úrazovej chirurgie, Nemocnica Spišská Nová Ves 4;  V. interná klinika LFUK a UNB, Bratislava, Slovensko 5;  Interné oddelenie, Dolnooravská NsP MUDr. L. Nádaši Jégého, Dolný Kubín, Slovensko 6
Published in: Cesk Slov Neurol N 2022; 85(3): 235-238
Category: Original Paper
doi: https://doi.org/10.48095/cccsnn2022235

Overview

Aim: The aim of this study was to examine the cross-sectional area (CSA) of the median nerve using ultrasound in acromegalic patients and to assess the relationship between the CSA of the median nerve and the activity, duration of acromegaly and age of patients. Materials and methods: We prospectively examined the CSA of the median nerve in 107 acromegalic patients (70 women and 37 men) and in 77 healthy controls (51 women and 26 men) matched for age, sex and body mass index. The Student t-test and Pearson correlation were used for data analysis. Results: The CSA of the median nerve was significantly greater in acromegalic patients compared with healthy controls (0.12 ± 0.005 cm2 vs. 0.078 ± 0.003 cm2; P < 0.001). The average duration of acromegaly was 11 years, average serum insulin-like growth factor 1 (IGF-1) level was 249.9 ng/mL and average growth hormone (RH) level was 2.63 ng/mL. We confirmed a positive correlation between the serum levels of IGF-1 and CSA of the median nerve in acromegalic patients (R = 0.400, P < 0.001). We did not confirm a relationship between CSA of the median nerve and serum levels of GH, duration of acromegaly and age of patients. Conclusion: In our study, we confirmed enlargement of the median nerve in patients with acromegaly. This enlargement depends on IGF-1 levels and is not depend on the duration of acromegaly and age of the patients.

Keywords:

Growth hormone – ultrasonography – acromegaly – insulin-like growth factor 1


Sources

1. Capatina C, Wass JH. 60 years of neuroendocrinology: acromegaly. J Endocrinol 2015; 226(2): 141–160. doi: 10.1530/ JOE-15-0109.

2. Podgorski M, Robinson B, Weissberger A et al. Articular manifestation of acromegaly. Aust N Z J Med 1988; 18(1): 28–35. doi: 10.1111/ j.1445-5994.1988.tb02236.x.

3. Baum H, Ludecke DK, Hermann HD. Carpal tunnel syndrome and acromegaly. Acta Neurochir 1986; 83(1–2): 54–55. doi: 10.1007/ BF01420508.

4. Vouzouneraki K, Esposito D, Mukka S et al. Carpal tunnel syndrome in acromegaly: a nationwide study. Eur J Endocrinol 2021; 184(2): 209–216. doi: 10.1530/ EJE-20-0530.

5. Tagliafico A, Resmini E, Nizzo R et al. Ultrasound measurement of median and ulnar nerve cross-sectional area in acromegaly. J Clin Endocrinol Metab 2008; 93(3): 905– 909. doi: 10.1210/ jc.2007-1719.

6. Jenkins PJ, Sohaib SA, Akker S et al. The pathology of median neuropathy in acromegaly. Ann Intern Med 2000; 133(3): 197–201. doi: 10.1530/ EJE-08-0327.

7. Keskin FE, Yetkin DO, Ozkaya HM et al. The problem of unrecognized acromegaly: surgeries patients undergo prior to diagnosis of acromegaly. J Endocrinol Invest 2015; 38(6): 695–700. doi: 10.1007/ s40618-015-0245-3.

8. Caron P, Brue T, Raverot G et al. Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study. Endocrine 2019; 63(1): 120–129. doi: 10.1007/ s12020-018-17 64-4.

9. Alibas H, Gogas Yavuz D, Kahraman Koytak P et al. Peripheral nervous system assessment in acromegaly patients under somatostatin analogue therapy. J Endocrinol Invest 2017; 40(1): 33–40. doi: 10.1007/ s40618- 016-0522-9.

10. Resmini E, Tagliafico A, Nizzo R et al. Ultrasound of peripheral nerves in acromegaly: changes at 1-year follow- up. Clin Endocrinol (Oxf) 2009; 71(2): 220–225. doi: 10.1111/ j.1365-2265.

11. Kocak M, Civan N, Karkucak M et al. Ultrasonographic assessment of soft tissues in patients with acromegaly. Arch Rheumatol 2015; 30(2): 138–143. doi: 10.5606/ ArchRheumatol.2015.5158.

12. Fu T, Cao M, Liu F et al. Carpal tunnel syndrome assesment with ultrasonography: value of inlet-to-outlet median nerve arearation in patients versus healthy volunteers. PloS One 2015; 10(1): e0116777. doi: 10.1371/ journal. pone.0116777.

13. Kim J, Kim M, Ko Y. Correlating ultrasound findings of carpal tunnel syndrome with nerve conduction studies. Muscle Nerve 2013; 48(6): 905–910. doi: 10.1002/ mus.23841.

14. Sample Size Calculator for Comparing Two Independent Means. [online]. Available from URL: https:/ / statulator. com/ SampleSize/ ss2M.html.

15. Giustina A, Barkan A, Casanueva FF et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 2000; 85(2): 526–529. doi: 10.1210/ jcem.85.2.6363.

16. Siegel S, Streetz-van der Werf C, Schott JS et al. Diagnostic delay is associated with psychosocial impairment in acromegaly. Pituitary 2013; 16(4): 507–514. doi: 10.1007/ s11102-012-0447-z.

17. Lugo G, Pena L, Cordido F. Clinical manifestation and diagnosis of acromegaly. Int J Endocrinol 2012; 2012: 540398. doi: 10.1155/ 2012/ 540398.

18. Ságová I, Pávai D, Kantárová D et al. Influence of diseasse activity and body composition parameters on cross sectional area of the median nerve in acromegalic patients. Physiol Res 2021; 70(6): 921–929. doi: 10.33549/ physiolres.934681.

19. Miller A, Doll H, David J et al. Impact of musculoskeletal disease on quality of life in long-standing acromegaly. Eur J Endocrinol 2008; 158(5): 587–593. doi: 10.1530/ EJE-07-0838.

20. Kameyama S, Tanaka R, Hasegawa A et al. Subclinical carpal tunnel syndrome in acromegaly. Neurol Med Chir 1993; 33(8): 547–551. doi: 10.2176/ nmc.33.547.

21. Atroshi I, Englund M, Turkiewicz A et al. Incidence of physician-diagnosed carpal tunnel syndrome in the general population. Arch Intern Med 2011; 171(10): 943– 944. doi: 10.1001/ archinternmed.2011.203.

22. Pourmemari MH, Shiri R. Diabetes as a risk factor for carpal tunnel syndrome: a systematic review and meta-analysis. Diabet Med 2016; 33(1): 10–16. doi: 10.1111/ dme.12855.

23. Tseng CH, Liao CC, Kuo CM et al. Medical and nonmedical correlates of carpal tunnel syndrome in a Taiwan cohort of one million. Eur J Neurol 2012; 19(1): 91–97. doi: 10.1111/ j.1468-1331.2011.03440.x.

24. Lakshminarayanan K, Shah R, Li ZM. Sex-related differences in carpal arch morphology. PLoS One 2019; 14(5): e0217425. doi: 10.1371/ journal.pone.0217 425.

25. Al-Rousan T, Sparks JA, Pettinger M et al. Menopausal hormone therapy and the incidence of carpal tunnel syndrome in postmenopausal women: findings from the Women’s Health Initiative. PLoS One 2018; 13(12): e0207509. doi: 10.1371/ journal.pone.0207509.

26. Alibas H, Gogas Yavuz D, Kahraman Koytak P et al. Peripheral nervous system assessment in acromegaly patients under somatostatin analogue therapy. J Endocrinol Invest 2017; 40(1): 33–40. doi: 10.1371/ journal. pone.0207509.

27. Sasagawa Y, Tachibana O, Doai M et al. Median nerve conduction studies and wrist magnetic resonance imaging in acromegalic patients with carpal tunnel syndrome. Pituitary 2015; 18(5): 695–700. doi: 10.1007/ s11102- 015-0642-9.

28. Reid TJ, Post KD, Bruce JN et al. Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol 2010; 72(2): 203– 208. doi: 10.1111/ j.1365-2265.2009.03626.x.

29. Danilowicz K, Fainstein Day P, Manavela MP et al. Implementing a screening program for acromegaly in Latin America: necessity versus feasibility. Pituitary 2016; 19(4): 370–374. doi: 10.1007/ s11102-016-0714-5.

30. Boguszewski CL. Acromegaly: „you must know it to think of it“. Eur J Endocrinol 2020; 183(1): C1–C4. doi: 10.1530/ EJE-20-0281.

31. Lenders NF, McCormack AI, Ho KKY. Management of endocrine disease: does gender matter in the management of acromegaly? Eur J Endocrinol 2020; 182(5): R67–R82. doi: 10.1530/ eje-19-1023.

32. El Miedany YE, Gaafary ME, Youssef S et al. Ultrasound assessment of the median nerve: a biomarker that can help in setting a treat to target approach tailored for carpal tunnel syndrome patients. Springerplus 2015; 4: 13. doi: 10.4236/ ojmn.2019.93024.

33. Azami A, Maleki N, Anari H et al. The diagnostic value of ultrasound compared with nerve conduction velocity in carpal tunnel syndrome. J Rheum Dis 2014; 17(6): 612– 620. doi: 10.1111/ 1756-185X.12310.

Labels
Paediatric neurology Neurosurgery Neurology
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#